Home | Search | Results place holder

Search Results



place holder place holder place holder place holder place holder place holder place holder place holder

Results for 'COX-2 Inhibitors'

Title Sort Publication Date Sort Price Sort Relevance Sort
place holder


EU Pharma IMPACTS

 August 2005 £450 35 %
Rheumatoid Arthritis: Emerging drug discovery targets
And therapeutic candidates

 October 2003 £375 32.2 %
Drug Safety in the Post-Vioxx Era
New legislation, regulation and company strategies in Europe and the US

 January 2005 £1495 32 %
Enzyme Inhibitors with Broad Therapeutic Applications

 June 2006 £3255 30.1 %
The Pain Market Outlook to 2011

 June 2006 £1495 28.35 %
Autoimmune Market Outlook to 2012

 August 2007 £1495 24.15 %
Cancer Drug Discoveries: Colorectal Cancer

 August 2005 £795 23.8 %
The Global Market for Pain Management Drugs and Devices

 June 2001 £3255 22.75 %
Therapeutics for Inflammatory Diseases
Current Challenges and Future Market

 March 2006 £3255 22.05 %
New Drug Futures: Musculoskeletal Chapter

 May 2006 £695 21 %
Stakeholder Opinions: Percutaneous Coronary Intervention
Adverse events with drug-eluting stents demand a new safety standard

 April 2008 £2005 20.65 %
Opportunities and Challenges for Generic Drugs in the UK 2007

 June 2007 £795 20 %
United States Pharmaceuticals and Healthcare Report Q3 2006

 July 2006 £395 19.6 %
Commercial Insight: Osteoarthritis
Market sees steady growth

 December 2006 £8000 19.25 %
Why Do Drugs Fail?

 November 2008 £995 18.55 %
Pipeline Insight: Osteoarthritis
The Wait for a DMOAD Continues

 November 2006 £6000 18.2 %
Pipeline Insight: Antithrombotics
Anticoagulants and Antiplatelets Have Blockbuster Potential

 October 2005 £6495 18.2 %
Pain Therapeutics 2005
Market Dynamics and Outlook

 May 2005 £1340 17.15 %
Top 7 Cancer Indications
Therapeutic & Competitive Insights

 January 2007 £5835 16.45 %
Cancer Drug Discoveries
What the Future Holds

 August 2005 £1995 16.1 %
Burger's Medicinal Chemistry and Drug Discovery
6 Volume Set

 March 2003 £1331 15.75 %
Pipeline Insight: Nociceptive Pain
Safety Profile Uppermost in Crowded Market

 October 2004 £6000 15.75 %
Migraine
A market focus

 August 2004 £885 15.05 %
Canada Pharmaceuticals & Healthcare

 September 2006 £395 14.5 %
World Neurodegeneratives Disease Markets

 February 2005 £1499 14 %
The Global Pain Therapeutics Market
Market Analysis, R&D Pipelines and Competitive Landscape

 October 2007 £1015 12.6 %
Nitric Oxide
Therapeutics, Markets and Companies

 September 2008 £1005 12.25 %
Pain Therapeutics
Drugs, Markets and Companies

 September 2008 £1075 11.9 %
Novel Targets in Drug Discovery
A new era in therapy

 April 2004 £595 11.9 %
Pharmaceutical R&D Productivity
The Path to Innovation

 October 2005 £1945 11.2 %
Stakeholder Opinions: Osteoarthritis
Preconceptions Damage Awareness and Treatments

 March 2006 £2195 10.85 %
Global Ophthalmic Market Analysis & Forecasts to 2012

 April 2007 £1499 10.5 %
Neurodegenerative Disease Drug Market Analysis and Forecasts 2007

 June 2007 £1999 10.15 %
Drug Approval Trends at the FDA and EMEA
Process Improvements, Heightened Scrutiny and Industry Response

 April 2008 £1995 9.5 %
Triple Progress Analysis: Melanoma, Colorectal & Lung Cancer

 March 2006 £2895 9.45 %
New Therapeutics and Diagnostics for Women’s Disorders

 May 2005 £3045 6.65 %
Cardiac Toxicity

 March 2008 £1495 6.5 %
Biotech 2010

 June 2006 £3255 6.3 %
Personalized Medicine
scientific & commercial aspects

 September 2008 £2680 6.3 %
Live-Licensing & In-life Testing
R&D Processes and Regulation for New Drugs, 2008-2020

 January 2008 £1499 3.5 %
place holder